M.I.TECH Co.,Ltd
Research M.I.TECH Co.,Ltd (179290.KQ) on Bullrun: market cap KRW 142.73B, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker179290.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyKRW
- Market capKRW 142.73B
- Dividend yield2.7%
- Financial periodQ2 2026
- RevenueKRW 19.75B
- Net incomeKRW 5.83B
- Free cash flow-KRW 2.65B
- Gross margin58.0%
Valuation Snapshot
latest market cap is KRW 142.73B; dividend yield is 2.7%.
Peer valuation comparison
Latest dividend yield is 2.72% versus a Healthcare sector median of 2.4% (13.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 142.73B | n/a | 2.7% | 120 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 120 KRW, yield 2.7%.
About M.I.TECH Co.,Ltd
M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective component in non-invasive way and instantly check skin condition before and after treatment.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is M.I.TECH Co.,Ltd's market cap?
M.I.TECH Co.,Ltd's market capitalization is KRW 142.73B.
Does M.I.TECH Co.,Ltd pay a dividend?
M.I.TECH Co.,Ltd has a dividend yield of 2.7%.
What does M.I.TECH Co.,Ltd do?
M.I.TECH Co.,Ltd engages in the provision of various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and glucometers under the GBIO BASE and RAPICHECK brand names. It also provides beauty systems, such as BRT system which is used in cleansing skin and inject the effective component in non-invasive way; and ClearView which is used in injecting the effective component in non-invasive way and instantly check skin condition before and after treatment. The company was formerly known as Solco Intermed Co., Ltd.